• MIT Researchers Identifies Electricity-Producing Bacteria

    Share Now56sharesFacebook56TwitterGoogle+Pinterest0MIT Researchers Identifies Electricity-Producing Bacteria By: Jennifer Chu | MIT News Office Living in extreme conditions requires creative adaptations. For certain species of bacteria that exist in oxygen-deprived environments, this means finding a way to breathe that doesn’t involve oxygen. These hardy microbes, which can be found deep within [..]

  • Collision 2019, Toronto | 1 Ticket For Many Conferences

    Share Now4sharesFacebook4TwitterGoogle+Pinterest0Collision 2019, Toronto 1 Ticket = Access to many conferences Conferences at Collision Collision is not a singular conference, but one that is home to many independent conferences. Each features its own stage, schedule, exhibition area, workshops, evening networking events and more. Thousands of digital marketers will fly from [..]

  • New materials could ‘drive wound healing’ by harnessing natural healing methods

    Share Now15sharesFacebook15TwitterGoogle+Pinterest0New materials could ‘drive wound healing’ by harnessing natural healing methods By: Imperial College London Materials are widely used to help heal wounds: Collagen sponges help treat burns and pressure sores, and scaffold-like implants are used to repair bones. However, the process of tissue repair changes over time, so scientists [..]

  • Future Technology for Contactless Procedures

    Share Now3sharesFacebook3TwitterGoogle+Pinterest0Future Technology for Contactless Procedures By: University of Bristol News Surgeons won’t be shrunk and sent into the body like in the 1960s Sci-Fi, Fantastic Voyage, but could program a specialized array of mini-speakers to create an intricate sound field that ‘traps’ and manipulates selected objects in ‘acoustic tweezers’ [..]

  • New Drug Combination Could be More Effective Against Melanoma

    Share Now7sharesFacebook7TwitterGoogle+Pinterest0New Drug Combination Could be More Effective Against Melanoma By: Anne Trafton | MIT News Office A class of cancer drugs called protein kinase inhibitors is one of the most effective treatments for melanoma. However, in many cases, tumors eventually become resistant to the drugs and cause a relapse in [..]

  • FDA Approved Firdapse® :First  Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)

    Share Now1sharesFacebook1TwitterGoogle+Pinterest0FDA Approved Firdapse® :First  Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) By: Catalyst Pharmaceuticals, Inc. NEWS Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, announced that the U.S. Food and Drug Administration (FDA) has approved [..]

  • Novartis announces landmark EU approval for one-time gene therapy Luxturna® to restore vision in people with rare inherited retinal disease

    Share Now1sharesFacebook1TwitterGoogle+Pinterest0Novartis announces landmark EU approval for one-time gene therapy Luxturna® to restore vision in people with rare inherited retinal disease By: Novartis News Novartis announced today that the European Commission (EC) approved Luxturna, a one-time gene therapy for the treatment of patients with vision loss due to a genetic mutation in [..]

  • FDA Grants Accelerated Approval to Genentech’s Venclexta® for Acute Myeloid Leukemia

    Share Now14sharesFacebook14TwitterGoogle+Pinterest0FDA Grants Accelerated Approval to Genentech’s Venclexta® for Acute Myeloid Leukemia By: Genentech News Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Venclexta® (venetoclax), in combination with a hypomethylating agent (azacitidine or decitabine), [..]

  • Study Opens Route to Ultra-Low-Power Microchips

    Share Now1sharesFacebook1TwitterGoogle+Pinterest0Study Opens Route to Ultra-Low-Power Microchips By: David L. Chandler | MIT News Office A new approach to controlling magnetism in a microchip could open the doors to memory, computing, and sensing devices that consume drastically less power than existing versions. The approach could also overcome some of the [..]

  • FDA Approves Novartis Drug Promacta® for First-line SAA |Breakthrough Therapy Designation

    Share Now2sharesFacebook2TwitterGoogle+Pinterest0FDA Approves Novartis Drug Promacta® for First-line SAA |Breakthrough Therapy Designation By: Novartis News Basel, November 16, 2018 – Novartis announced today that the US Food and Drug Administration (FDA) has expanded the label for Promacta®(eltrombopag) to include first-line treatment for adults and pediatric patients two years and older with SAA [..]

  • Liquid Fuel That Can Store The Sun’s Energy For Up to 18 Years

    Share Now1sharesFacebook1TwitterGoogle+Pinterest0Liquid Fuel That Can Store The Sun’s Energy For Up to 18 Years Originally Published at www.sciencealert.com  No matter how abundant or renewable, solar power has a thorn in its side. There is still no cheap and efficient long-term storage for the energy that it generates. The solar industry [..]